Comparison of anti‑inflammatory and analgesic effects of Ginger powder and Ibuprofen in postsurgical pain model: A randomized,double‑blind,case–control clinical trial by Rayati, Farshid et al.
Dental Research Journal
1© 2017 Dental Research Journal | Published by Wolters Kluwer - Medknow
Original Article
Comparison of anti‑inflammatory and analgesic effects of Ginger 
powder and Ibuprofen in postsurgical pain model: A randomized, 
double‑blind, case–control clinical trial
Farshid Rayati1, Fatemeh Hajmanouchehri2, Elnaz Najafi3
1Department of Oral and Maxillofacial Surgery, Dental Caries Prevention Research Center, Qazvin University of Medical Sciences, 2Department of 
Clinical and Anatomical Pathology, Qazvin University of Medical Sciences, Qazvin, 3Department of Orthodontics, School of Dentistry, Islamic Azad 
University of Isfahan, Isfahan, Iran
ABSTRACT
Background: Ginger has been used as an herbal drug for a long time for the treatment of chronic 
inflammatory conditions.
Materials and Methods: This randomized, double‑blind clinical trial was conducted on 67 healthy 
adults with at least one impacted lower third molar. Participants were randomly allocated into three 
groups: Ibuprofen, Ginger, and placebo. Evaluation of inflammation was done by measuring cheek 
swelling, mouth opening ability, serum C‑reactive protein (CRP) levels, and visual analog scale (for 
pain scoring). The number and the time of using rescue medication were recorded too.
Results: Sixty patients completed the study. In all three groups, there was a significant increase in 
the mean cheek swelling measures, compared with the baseline, until day 5. The reduction in mouth 
opening ability was significant in all three groups, compared with the baseline, until day 5. There was 
no significant difference between ibuprofenand ginger groups in pain scores in all follow‑up days. 
Number of required rescue medication on the day of surgery was significantly more in the placebo 
group. No significant or strong correlations were found between CRP levels and clinical findings.
Conclusion: Within the limitations of this study, it can ban be concluded that gingerpowder is as 
effective as ibuprofenin the management of postsurgical sequelae. Furthermore, CRP levels alone 
are not suggested for the assessment of anti‑inflammatory effects of drugs.
Key Words: C‑reactive protein, Ginger, Ibuprofen, surgery, third molar
INTRODUCTION
Ginger, the rhizome of Zingiber officinale, has been 
used as an herbal drug for a long time. In traditional 
Chinese and Indian medicine, gingerhas been used 
to treat a wide range of diseases including stomach 
ache, diarrhea, nausea, asthma, respiratory disorders, 
toothache, gingivitis, and arthritis. A number of 
studies have shown interest in gingerfor the treatment 
of chronic inflammatory conditions. This interest 
can be traced to the discovery in the early 1970s 
that nonsteroidal anti‑inflammatory drugs (NSAIDs) 
insert their effects by inhibiting the biosynthesis of 
prostaglandins (PGs). Soon thereafter, ginger was 
found to contain constituents that inhibit PG synthesis 
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too. This finding provided a sound scientific rationale 
for its anti‑inflammatory effects. Subsequent studies 
revealed that some of the constituents of ginger have 
pharmacological properties similar to the novel class 
of dual-acting NSAIDs. Compounds in this class can 
inhibit arachidonic acid metabolism through both 
the cyclooxygenase (COX) and lipoxygenase (LOX) 
pathways and have notably fewer side effects than 
conventional NSAIDs.[1,2] Different animal studies 
revealed that orally prescribed dried ginger or ginger 
extract can reduce acute inflammation.[3-6] Several 
clinical studies support the value of ginger for the 
treatment of osteoarthritis, and in some cases, a 
significant reduction in knee pain was reported.[1,7-9] 
In some of these trials, it was resulted that Ginger 
relieved pain and swelling to varying degrees in 
patients with osteoarthritis, rheumatoid arthritis, and 
muscular pain without causing serious adverse effects 
even after long periods of use.[10] Ozgoli et al. tested 
ginger in primary dysmenorrhea in comparison with 
ibuprofen and mefenamic acid, and no significant 
differences were found between the study groups in 
relief, stability, or aggravation of symptoms.[11]
In this study, dental pain model is used because it is a 
widely employed, validated, and highly standardized 
acute pain model and is the most appropriate model 
to investigate the onset of analgesic action.[12] The 
model is widely accepted and has a proven record 
of assay sensitivity. Therefore, it is often used as the 
primary clinical pain model for the investigation of 
analgesic drugs.[13] Compounds with anti‑inflammatory 
properties provide better analgesia than centrally 
acting analgesics in this model.[12]
The common postoperative sequelae of surgical 
removal of impacted teeth are pain, trismus, and 
swelling with COX and PGs playing a central 
role.[13] The efficacy of ibuprofen in the treatment 
of postoperative dental pain has been demonstrated 
in several clinical trials. However, NSAIDs are 
contraindicated in patients with gastrointestinal 
ulcers, bleeding disorders, and renal dysfunctions.[13-17] 
Therefore, there is a need for an effective analgesic 
with a more favorable safety profile. In the literature, 
despite high anti‑inflammatory potential of ginger 
constituents, it was used mainly against chronic 
inflammatory conditions while its effect on acute 
inflammation was assessed in animal studies and rare 
clinical trials. Therefore, our aim was to investigate 
the ability of ginger powder to reduce postoperative 
sequelae after mandibular third molar surgery.
MATERIALS AND METHODS
The protocol of this randomized, double-blind, 
placebo-controlled study was approved by the Ethics 
Committee of the local institution in Qazvin. In the 
limited time of 12 months, all patients fulfilling 
the criteria of the study were entered. All the study 
protocols were explained to each patient, and an 
informed written consent was obtained from all 
volunteers.
Patients
Sixty-seven outpatients undergoing elective surgical 
removal of impacted mandibular third molars 
participated in the present study. All patients were 
of the American Society of Anesthesiologists class I, 
aged 18–35 of either sex, with at least high school 
graduation diploma educational degree and at least 
one impacted mandibular third molar. Reasons for 
exclusion from the study were known allergy to the 
study medications, pregnancy or lactating, history 
of peptic ulceration, history of corticosteroid use, 
history of any kind of inflammatory conditions or 
taking any medication since 1 month before surgery, 
duration of surgery more than 30 min, any infection, 
fever or suffering any kind of disease during the 
following days, any mouthwash (except normal 
saline) or applying ice pack use during the following 
days, failure to attend the follow-up, using any kind 
of medication other than prescribed in this study, 
mentally incapable of understanding or complying 
with the study protocol, or refusing to sign the 
informed consent.
Baseline investigations including a panoramic view 
of the jaws and clinical evaluation of the third molars 
were done by a single oral and maxillofacial surgeon 
to  score the difficulty.[18]
Study design
Patients fulfilling the criteria were randomly 
allocated into one of the three groups to receive 
one capsule of ginger containing 500 mg of ginger 
rhizome powder (Zintoma; Goldaru Co., Iran), one 
capsule of ibuprofen 400 mg (ibuprofen; Arya Co., 
Iran), or placebo. All medications were prepared 
by a pharmacist and packed in similar capsules 
and packages. All the packages were coded by the 
pharmacist. Operator, and other members of the team 
had no knowledge of the medications under each 
code. The placebo was a capsule containing starch. 
All medications were administered orally and 6 
hourly. The first dose was administered immediately 
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after completion of surgery and before terminating of 
the anesthetic effect. Rescue medication in the form 
of acetaminophen (500 mg with at least 4 h intervals) 
was allowed when required after surgery for all the 
patients. Patients were encouraged not to use any 
rescue medication for the first 4 h postoperatively. The 
time and number of rescue medication each patient 
took was recorded by the patient in the prepared 
questioners. All patients received amoxicillin 500 mg 
8 hourly for 1 week postoperatively to prevent 
infection of the surgical site.
All the surgeries were accomplished by a single 
maxillofacial surgeon. Surgery was carried out under 
routine local anesthesia (lidocaine 2% +1:80,000 
epinephrine, inferior alveolar nerve block with long 
buccal nerve block). The surgical procedure consisted 
of a buccal incision started from ascending ramus 
to the mesial of second molar, mucoperiosteal flap 
elevation, buccal and distal bone removal, splitting 
and elevation of the impacted tooth, rinsing the socket 
by normal saline and interrupted simple suturing 
using 3/0 braided silk. The exact time at which 
surgery ended, duration of each operation and the 
quantity of the consumed local anesthetic cartridges 
were recorded. Written forms containing standard 
postoperative instructions were given to patients in 
addition to researchers’ explanations. Patients were 
not allowed to use any kind of mouthwashes (except 
normal saline) or ice packs until the last follow‑up 
day. After surgery, it was explained for all patients 
how they have to use the medications and fill in the 
questionnaires.
Postoperatively, parameters of cheek swelling, pain, 
amount of mouth opening, and serum high-sensitivity 
C‑reactive protein (hsCRP) concentration were 
measured. Cheek swelling was recorded by cheek 
thickness measurement using  standard calipers,[18] 
from the mucosal lingual aspect of the cheek opposite 
to the mid-portion of the crown of the mandibular 
first molar to the tangent of the skin of the cheek, 
before surgery (baseline) and on days 1, 3, and 
5 postoperatively. To have similar and consistent 
amount of mouth opening in patients at the time of 
measuring the cheek thickness, we used a modified 
bite block in premolar area for all patients. With 
this bite block, patients had the minimum amount of 
mouth opening (4–5 mm), in which measuring the 
cheek thickness was possible.
Mouth opening ability was assessed by measuring 
the distance between the upper and lower central 
incisal edges at maximal mouth opening before 
surgery (baseline) and on days 1, 3, and 5 after 
surgery. Pain was assessed using a 100 mm visual 
analog scale (VAS) stretching from “no pain” (0 mm) 
to “the worse pain I’ve ever had” (100 mm) before 
surgery, at 1 h intervals in the first 12 h following 
the surgery and every 6 h until day 4 after surgery. 
Pain intensity measurement was made by the patient 
at home and in prepared questionnaires. To measure 
serum CRP concentrations, the first venous blood 
sample (4 ml) was collected immediately after surgery 
and before taking the medication and the second 
sample was collected 72 h after surgery (5 ml). 
Samples immediately delivered to the laboratory and 
centrifuged. The separated serums were assessed 
using sandwich ELISA technique to quantitatively 
determine CRP concentrations.
Any adverse drug reaction during the study was 
recorded by patients or the investigator.
Statistical analysis
Statistical analysis was performed using SPSS 
version 15(SPSS Inc. IBM Corporation). Repeated 
measure and ANOVA tests were used to assess the 
significance of changes of mean cheek swelling (mCS) 
and mean maximum mouth opening (mMMO). To 
analyze the VAS scores’ variations, Mann–Whitney 
and ANOVA tests were used. To assess the changes in 
CRP amounts and the correlation between CRP levels 
and clinical symptoms, ANOVA test and Pearson 
correlation coefficient were used, respectively. 
Statistical significance was assumed at 0.05.
RESULTS
Out off 67 participants entered into the study 
(26 men, 41 women), seven (two men, five women) 
were excluded due to two follow-up visits failure, 
one because blood sampling was not possible, two for 
catching cold in the follow-up days, one for not taking 
the drugs, and one for reporting heartburn on the 
second day after surgery. Hence, data of sixty patients 
were analyzed. There were no significant differences 
in demographic and baseline characteristics, operation 
time, and amount of consumed local anesthetic for the 
surgery [Table 1].
Parameters of mouth opening and cheek swelling 
were assessed three times in each follow-up visit, 
and the mean was used in analyses [Tables 2 and 3]. 
The mean amount of cheek swelling (mCS) and mean 
amount of mMMO were recorded in the follow-up 
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days (baseline, days 1, 3, and 5 postoperatively) and 
their changes were assessed in and between groups. 
In the intergroup assessment, the amount of mCS 
and mMMO of each drug in each follow-up day was 
compared to the baseline and to the first postoperative 
day (in which the maximum amount of mCS and 
minimum amount of mMMO were observed). In 
the intragroup assessment, the amount of mCS and 
mMMO changes of each drug in each follow-up day 
was compared with other drugs. Regarding mCS, the 
intergroup assessments demonstrated that in all three 
groups, there was a significant increase in the mCS 
compared with the baseline until day 5. In addition, in 
all three groups, no significant reduction in amounts 
of mCS was observed on days 3 and 5 compared 
with day 1. The intragroup assessment showed no 
significant differences of mCS changes in follow‑up 
days between three groups.
In all follow‑up days, no significant increase in the 
amount of mMMO was observed in follow-up days 
compared with the baseline in any of three groups. In 
addition, there was no significant increase in amounts 
of mMMO on days 3 and 5 compared with day 1. 
There was no significant difference between three 
groups and in any of the follow-up days in mMMO 
amounts.
There was no significant difference in CRP 
concentrations in the immediate postoperative samples 
among the groups. Blood samples collected 72 h 
postoperatively showed significant elevations in CRP 
levels. However, this difference was not significant 
between the groups. Correlations of CRP levels 
and severity of clinical symptoms (VAS, mCS and 
mMMO) between day 3 and baseline were assessed 
too. Results revealed no significant and strong 
correlations between these parameters.
There was no significant difference in presurgical pain 
intensity between groups [Table 4 and Figure 1]. In 
all groups, the maximum pain score was reported on 
the day of surgery (day 0). In this day, in ibuprofen 
and ginger groups, the mean pain score was in 
mild range (30–45), and in placebo group, it was in 
moderate range (45–70). There was no significant 
difference between ibuprofen and ginger groups in 
reported pain scores of the day of surgery (day 0); 
however, in some of the postoperative hours, ginger 
and ibuprofen decreased pain intensity significantly 
more than placebo. None of the groups showed 
a significant reduction in pain intensity scores on 
day 1 in comparison with day 0. In both ibuprofen 
and ginger groups, the mean pain scores were reduced 
significantly from day 2 onward in comparison with 
placebo, but this amount was not significantly different 
between ibuprofen and ginger groups. The mean 
pain intensity scores of days 1, 2, 3, and 4 were not 
significantly different between three groups [Table 5].
Data regarding the use of rescue medication in all 
groups are presented in Table 6. The placebo group 
Table 1: Demographic characteristics of the study 
patients (n=60), duration of surgery and amount of 
local anesthetic used (mean±standard deviation)
Demographic data Ibuprofen Placebo Ginger P
Gender
Women 13 10 13 NS*
Men 7 10 7
Ratio 1.8:01 1:01 1.8:01
Age 22±4.1 22±3.1 23±2.8 NS
Duration of surgery 14±5.3 14±5.09 16±5.8 NS
Number of anesthetic carpules 2.07 2.12 2.05 NS
*NS: No significant difference was found
Table 3: Mean of maximum mouth opening of 
patients on the day of surgery and follow‑up 
sessions (mean±standard deviation)
Treatment groups Day 0 (baseline) Day 1 Day 3 Day 5
Ibuprofen 46.3±7.5 32±10 32.5±10 36.3±11
Placebo 47.1±8.8 32.6±12 34.8±11 38.1±12
Ginger 45.1±8.1 32.9±10 32.5±11 35.3±10
Figure 1: Median pain score (mm) of three study groups on 
the day of surgery (day 0).
Table 2: Mean of cheek swelling of patients 
on the day of surgery and follow‑up sessions 
(mean±standard deviation)
Treatment groups Day 0 (baseline) Day 1 Day 3 Day 5
Ibuprofen 31.5±4.8 37.8±5 37±4.7 34.7±4.4
Placebo 30.9±5.5 36.4±6.3 35.9±5.8 33.8±4.5
Ginger 30.7±4.7 35.4±4.5 34.5±4.2 32.6±3.7
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required acetaminophen significantly more than 
other groups on the day 0. In placebo group, 80% of 
patients took their first rescue medication in the first 
2–4 h after surgery, but in other groups, only 35% of 
patients did.
No abnormal wound bleeding was observed in the 
follow-up sessions. Only two patients in Ginger group 
complained of their wound oozing 48 h after surgery. 
No adverse drug reactions that need any alteration in 
the treatment were reported.
DISCUSSION
The common postsurgical sequelae of third molar 
surgery are related to local inflammatory reactions 
with COX pathway and PGs playing an important role 
in it.[12] The efficacy of corticosteroids and NSAIDs 
which directly affect this inflammatory pathway has 
been evaluated in several studies.[14,16,17] In the present 
study, regarding the dual COX and LOX inhibitory 
reaction of ginger, we tried to assess ginger’s ability 
to control the postoperative sequelae of this acute 
pain model.
No significant differences were observed in mean mouth 
opening ability and mCS between ibuprofen, ginger, 
and placebo groups. All patients were experienced 
their greatest level of pain on the day of surgery with 
a peak of 4 h after surgery which was in the range of 
previous studies’ reports. On the surgery day and all 
postoperative follow‑up days, ginger was as effective 
as ibuprofen in reducing postoperative pain intensity. 
The total number of used rescue medications was 
not significantly different between groups; however, 
on the day of surgery, the placebo group took rescue 
medication two times more than the other groups.
Ibuprofen is the most commonly used drug for pain 
relief after oral surgery. In the previous studies, 
ibuprofen was not superior to placebo in reducing 
postoperative swelling but was significantly effective 
in reducing the pain on the day of surgery.[14] Our 
results about ibuprofen confirmed the earlier studies. 
It has been shown that ginger was as effective as 
ibuprofen and mefenamic acid in relieving menstrual 
pain.[11] Different studies have assessed the efficacy of 
ginger in reducing osteoarthritic pain and symptoms. 
Haghighi et al. indicated that ginger extract could be 
used as an alternative to ibuprofen and as a supplement 
drug in patients with osteoarthritis.[9] Bliddal et al. 
found that ibuprofen was significantly more effective 
than ginger and ginger was significantly more effective 
than placebo in relieving chronic pain and the same 
trend was found for acetaminophen consumption.[8] 
In a crossover study, Wigler et al. reported that in the 
12 weeks period of the first phase (before crossover), 
ginger showed the placebo effect, but at the end of the 
second phase and after 24 weeks, the groups reached 
a statistically significant difference. They concluded 
that these results were due to delayed effect of ginger 
extract and lack of a washout period in the research.[7] 
Following reasons limit the exact comparison of our 
results with the previously mentioned studies: Chronic 
inflammatory process of assessed disease, a different 
form of prescribed ginger (extract vs. powder), duration 
Table 4: Median pain score (mm) on the day of 
surgery (day 0) (median±standard error)
Symptoms According to the 
drug used
Treatment groups
Ibuprofen Placebo Ginger
Before surgery 0 0 0
After 1 h 11.9±3.8 16.6±5 22.9±7.6
After 2 h 23.2±5.8 45.4±6.9 30.6±7.5
After 3 h 34.6±7.5 56±5.7 35.9±6.7
After 4 h 35.2±7.2 55±4.6 37.9±6.5
After 5 h 33.5±7.3 44.3±4.4 36.5±5.8
After 6 h 30.8±6.9 42.3±4 35±6.3
After 7 h 26.9±6.8 38±4.2 29.3±6.7
After 8 h 24.2±6.2 39.5±4.2 29.9±6.9
After 9 h 21±6.6 36.5±4.3 31.5±7.6
After 10 h 15.4±5.5 31.4±4.7 30.5±7.6
After 11 h 16.6±5.5 27.9±3.5 27.5±6.6
After 12 h 19.5±6.4 24.1±3.1 24.6±6.3
Table 5: Mean pain score (mm), day 0 through 
day 4 (mean±standard deviation)
Treatment group Day 0 Day 1 Day 2 Day 3 Day 4
Ibuprofen 24.4±5.3 17.2±5.3 12±3.7 8.4±2.8 9.7±3.1
Placebo 38.1±3 18.4±2.3 10±2.7 6.5±2.5 3.5±1.8
Ginger 31±6.1 19±5.8 16±5.6 15.1±5.2 13±4.3
Table 6: Amount and time of used rescue medications
Treatment 
group
Number of patients 
used rescue medication
Total number of used 
rescue medication
Number of rescue 
medication taken on day 0
Amount of time passed before 
taking first rescue medication (min)
Ibuprofen 21 40 17 218
Placebo 28 53 33 204
Ginger 22 51 18 221
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of treatment, and difference in assessed clinical signs 
and symptoms. In our study, the difference between 
ibuprofen and ginger groups was not significant in 
any of the postoperative sequelae. Our results indicate 
that ginger was almost as effective as ibuprofen in 
relieving postoperative sequelae. In some of the 
studies which used third mandibular molar surgery 
pain model, only CRP concentration was assessed to 
indicate the anti‑inflammatory effect of different drugs 
and methods.[19,20] We found no strong or significant 
correlations between CRP levels and clinical 
symptoms in this study. Assessment of different ginger 
extracts and more specific inflammatory mediators 
besides clinical symptoms are our suggestions for 
further studies.
CONCLUSION
Within the limitations of this study, it can be 
concluded that ginger is as effective as ibuprofen 
in controlling postoperative sequelae, especially 
pain, and it can be an efficient substitute for this 
synthetic agents. Considering the standard deviation 
and interquartile range which indicated more data 
scattering in ginger group, however, it seems that 
ibuprofen, at least in some parts of the day of 
surgery, may be more efficient in pain control. 
Lack of significant correlations between CRP levels 
and severity of clinical symptoms makes using 
serum CRP concentrations as the only criteria for 
anti‑inflammatory effect assessment, inappropriate.
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